1 unchanged sentence
ITEM 6 – EXHIBITS
−Removed: The following exhibits are
−Removed: incorporated herein by reference or filed as part of this report.
+Added: The following exhibits are incorporated herein by
+Added: reference or filed as part of this report.
EXHIBIT NUMBER
−Removed: Exclusive Sublicense Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc.
−Removed: and CLS Therapeutics LTD
−Removed: Exclusive License Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc.
−Removed: and CLS Therapeutics LTD
−Removed: Form of Subscription Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc.
−Removed: and CLS Therapeutics LTD
−Removed: Statement of Work, dated June 30, 2022, between Xenetic Biosciences, Inc.
−Removed: and Catalent Pharma Solutions, LLC
Certification of Jeffrey F.
3 unchanged sentences
Eisenberg, Principal Executive Officer, and James Parslow, Principal Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in inline XBRL, include:
+Added: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in inline XBRL, include:
(i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Stockholders’ Equity, (iv) Condensed Consolidated Statements of Cash Flows and (v) the Notes to the Condensed Consolidated Financial Statements
8 unchanged sentences
Xenetic Biosciences, Inc.
−Removed: August 11, 2022
+Added: November 9, 2022
/S/ JEFFREY F.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.